On May 8, CVS/Caremark (NYSE:CVS) released first-quarter earnings for the period ended March 31.

  • The merger between CVS and Caremark closed on March 22, so the results reflect 10 days of the consolidated company.
  • Merger and integration expenses are estimated to have shortened earnings by $25.3 million, lowering shareholder profits a penny.
  • While increasing demand for generic drugs curtailed the top line, revenue still posted an impressive 32.1% surge.
  • Front-end comparable sales rose a solid 6.6%, driven primarily by health and beauty products, digital photo services, and private label and proprietary brand sales.

(Figures in millions, except per-share data.)

Income Statement Highlights

Q1 2007

Q1 2006

Change

Sales

$13,184.6

$9,979.2

32.1%

Net Profit

$405.4

$326.1

24.3%

EPS

$0.43

$0.39

10.3%

Diluted Shares

939.8

848.5

10.8%

Get back to basics with the income statement.

Margin Checkup

Q1 2007

Q1 2006

Change*

Gross Margin

25.4%

26.6%

(1.2)

Operating Margin

5.6%

5.6%

(0.0)

Net Margin

3.1%

3.3%

(0.2)

*Expressed in percentage points.

Margins are the earnings engine.

Balance Sheet Highlights

Assets

Q1 2007

Q1 2006

Change

Cash + ST Invest.

$738.2

$387.1

90.7%

Accounts Rec.

$4,485.4

$2,015.0

122.6%

Inventory

$7,427.1

$5,704.8

30.2%

Liabilities

Q1 2007

Q1 2006

Change

Accounts Payable

$3,371.1

$2,437.6

38.3%

Long-Term Debt

$2,895.4

$1,592.2

81.8%

The balance sheet reflects the company's health.

Cash Flow Highlights

Q1 2007

Q1 2006

Change

Cash From Ops.

$707.7

$171.7

312.2%

Capital Expenditures

$311.9

$283.7

9.9%

Free Cash Flow

$395.8

($112.0)

N/A

Free cash flow is a Fool's best friend.

Related Foolishness:

Fool by Numbers is designed to give you the raw earnings information in a timely fashion, putting all the numbers you need in one easy-to-read place. But at The Motley Fool, we believe numbers tell only part of the story, so check Fool.com for more of our in-depth discussion of what the numbers mean. This data has been provided by Netscribes. To provide feedback on this article, please click on the "feedback" button below.